Laporan Laba Rugi BXP - TTM - Beximco Pharmaceuticals Limited - Depositary Receipt (Common Stock)

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Beximco Pharmaceuticals Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31
Revenue	26,235	27,517	28,269	29,494	31,037	32,062	33,660	34,669	35,987	37,379	37,974	39,267	40,639	41,652	43,085	44,392	44,946	46,341
Change (%)		4.89	2.73	4.33	5.23	3.30	4.98	3.00	3.80	3.87	1.59	3.40	3.49	2.49	3.44	3.03	1.25	3.10
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	14,060	14,670	15,085	15,677	16,439	16,913	17,901	18,989	19,911	21,016	21,455	22,164	23,076	23,630	24,457	24,989	25,041	25,757
Change (%)		4.34	2.83	3.93	4.86	2.88	5.85	6.07	4.86	5.55	2.09	3.31	4.11	2.40	3.50	2.18	0.21	2.86
% of Revenue	53.59	53.31	53.36	53.15	52.97	52.75	53.18	54.77	55.33	56.22	56.50	56.45	56.78	56.73	56.76	56.29	55.71	55.58

Gross Operating Profit	12,175	12,847	13,184	13,816	14,598	15,149	15,758	15,681	16,076	16,363	16,519	17,102	17,563	18,021	18,628	19,403	19,905	20,584
Change (%)		5.52	2.62	4.80	5.66	3.78	4.02	-0.49	2.52	1.78	0.95	3.53	2.69	2.61	3.37	4.16	2.59	3.41
% of Revenue	46.41	46.69	46.64	46.85	47.03	47.25	46.82	45.23	44.67	43.78	43.50	43.55	43.22	43.27	43.24	43.71	44.29	44.42

SG&A	6,581	6,802	6,918	7,470	7,837	8,393	8,887	9,101	9,463	9,592	10,033	10,200	10,480	10,693	10,873	11,112	11,368	11,784
Change (%)		3.35	1.71	7.98	4.91	7.09	5.90	2.40	3.98	1.36	4.59	1.67	2.74	2.04	1.69	2.19	2.31	3.65
% of Revenue	25.09	24.72	24.47	25.33	25.25	26.18	26.40	26.25	26.30	25.66	26.42	25.98	25.79	25.67	25.24	25.03	25.29	25.43

R&D
Change (%)
% of Revenue

OpEx	20,641	21,471	22,003	23,147	24,276	25,306	26,789	28,089	29,374	30,609	31,488	32,365	33,556	34,323	35,330	36,101	36,409	37,541
Change (%)		4.02	2.48	5.20	4.88	4.24	5.86	4.85	4.57	4.20	2.87	2.78	3.68	2.29	2.93	2.18	0.85	3.11
% of Revenue	78.68	78.03	77.83	78.48	78.22	78.93	79.59	81.02	81.62	81.89	82.92	82.42	82.57	82.41	82.00	81.32	81.01	81.01

Operating Income	5,594	6,045	6,266	6,346	6,761	6,757	6,871	6,580	6,613	6,770	6,485	6,902	7,083	7,328	7,755	8,291	8,537	8,801
Change (%)		8.07	3.65	1.28	6.53	-0.06	1.69	-4.23	0.50	2.38	-4.21	6.42	2.62	3.46	5.82	6.91	2.97	3.09
% of Revenue	21.32	21.97	22.17	21.52	21.78	21.07	20.41	18.98	18.38	18.11	17.08	17.58	17.43	17.59	18.00	18.68	18.99	18.99

Interest Expense	-913	-954	-861	-806	-736	-735	-848	-926	-1,073	-1,138	-1,181	-1,242	-1,228	-1,169	-1,137	-1,121	-1,102	-1,037
Change (%)		4.51	-9.77	-6.35	-8.66	-0.10	15.37	9.10	15.92	6.04	3.80	5.14	-1.06	-4.85	-2.72	-1.42	-1.72	-5.85
% of Revenue	-3.48	-3.47	-3.04	-2.73	-2.37	-2.29	-2.52	-2.67	-2.98	-3.04	-3.11	-3.16	-3.02	-2.81	-2.64	-2.53	-2.45	-2.24

Net Income	3,724	4,017	4,578	5,128	5,519	6,097	5,738	5,123	5,105	4,629	4,477	4,614	4,720	4,916	5,330	5,830	5,957	6,354
Change (%)		7.85	13.98	12.00	7.62	10.48	-5.90	-10.71	-0.36	-9.32	-3.28	3.06	2.29	4.16	8.42	9.36	2.19	6.65
% of Revenue	14.20	14.60	16.20	17.39	17.78	19.02	17.05	14.78	14.19	12.38	11.79	11.75	11.61	11.80	12.37	13.13	13.25	13.71

Source: Capital IQ

Beximco Pharmaceuticals Limited - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings